Proxibarbital
Proxibarbital is a barbiturate derivative that has been used as a sedative and hypnotic agent. It is known for its central nervous system depressant effects, which are typical of barbiturates. Proxibarbital is less commonly used today due to the development of safer and more effective benzodiazepines and other sedative-hypnotic drugs.
Chemical Properties[edit]
Proxibarbital is a chemical compound with the molecular formula C13H18N2O3. It is a barbituric acid derivative, characterized by the presence of a pyrimidine ring structure. The chemical structure of proxibarbital includes a propyl group attached to the nitrogen atom, which influences its pharmacological properties.
Pharmacology[edit]
Proxibarbital acts on the gamma-aminobutyric acid (GABA) receptor complex, enhancing the inhibitory effects of GABA in the brain. This action results in sedation, anxiolysis, and hypnosis. Like other barbiturates, proxibarbital can cause respiratory depression and coma in overdose situations.
Clinical Use[edit]
Historically, proxibarbital was prescribed for the treatment of insomnia and anxiety. However, due to its potential for dependence and abuse, as well as the risk of overdose, its use has declined. Modern medicine prefers benzodiazepines and other non-barbiturate sedatives for these indications.
Side Effects[edit]
Common side effects of proxibarbital include drowsiness, dizziness, and headache. More severe side effects can include confusion, ataxia, and respiratory depression. Long-term use can lead to tolerance, dependence, and withdrawal symptoms upon discontinuation.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian